Ignite Creation Date:
2025-12-24 @ 4:27 PM
Ignite Modification Date:
2025-12-29 @ 5:56 AM
Study NCT ID:
NCT05996666
Status:
UNKNOWN
Last Update Posted:
2023-08-18
First Post:
2023-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Primary Liver Cancer Early Detection
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D008113', 'term': 'Liver Neoplasms'}], 'ancestors': [{'id': 'D004067', 'term': 'Digestive System Neoplasms'}, {'id': 'D009371', 'term': 'Neoplasms by Site'}, {'id': 'D009369', 'term': 'Neoplasms'}, {'id': 'D004066', 'term': 'Digestive System Diseases'}, {'id': 'D008107', 'term': 'Liver Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'CASE_CONTROL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 701}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'RECRUITING', 'startDateStruct': {'date': '2023-07-01', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2023-08', 'completionDateStruct': {'date': '2023-12', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2023-08-10', 'studyFirstSubmitDate': '2023-08-10', 'studyFirstSubmitQcDate': '2023-08-10', 'lastUpdatePostDateStruct': {'date': '2023-08-18', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2023-08-18', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2023-12', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Performance of liver cancer early detection model based on selected cfDNA methylation markers using qPCR', 'timeFrame': '2023.07.01-2023.12.30', 'description': 'Sensitivity and specificity of liver cancer detection model based on selected cfDNA methylation biomarkers using qPCR in subjects with primary liver cancer or benign liver diseases, interfering cancers and healthy individuals'}], 'secondaryOutcomes': [{'measure': 'Performance of the liver cancer early detection model in detecting liver cancer at early stage', 'timeFrame': '2023.07.01-2023.12.30', 'description': 'Sensitivity of the liver cancer early detection model in patients with small liver cancer lesions or AFP negative'}, {'measure': 'Performance of liver cancer early detection model in detecting liver cancer at different stages and subtypes', 'timeFrame': '2023.07.01-2023.12.30', 'description': 'Sensitivity of the liver cancer early detection model in different stages or different pathological subtypes'}, {'measure': 'Performance of liver cancer early detection model to differentiate non-liver cancers', 'timeFrame': '2023.07.01-2023.12.30', 'description': 'Specificity of the liver cancer early detection model to differentiate patients with benign liver diseases or different interfering cancer types from liver cancer'}, {'measure': 'Comparison of currently used biomarkers for liver cancer detection', 'timeFrame': '2023.07.01-2023.12.30', 'description': 'Comparison of the sensitivity and specificity of the liver cancer early detection model and other biomarkers of liver cancer in detecting early liver cancer'}]}, 'oversightModule': {'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['Early detection', 'Liver cancer', 'cell-free DNA (cfDNA)', 'qPCR'], 'conditions': ['Liver Cancer']}, 'descriptionModule': {'briefSummary': 'In the recently published multi-center, prospective, single-blind study (THUNDER study), using the methylation signal in cfDNA isolated from the peripheral blood to detect the six types of cancer, the sensitivity for liver cancer detection achieved 87.8%, with a specificity of 98.9%. In this study, a multicenter, case-control study is designed to establish an early cancer detection model based on cfDNA methylation biomarkers using qPCR to detect primary liver cancer and further validate the performance of the model.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '74 Years', 'minimumAge': '18 Years', 'samplingMethod': 'PROBABILITY_SAMPLE', 'studyPopulation': 'Participants enrolled in this study included subjects with primary liver cancers, benign liver diseases, interfering cancers, and healthy individuals.', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\nInclusion Criteria for all participants\n\n* Individuals aged 18-74 years old\n* Individuals capable of giving signed and legally effective informed consent voluntarily\n\nInclusion Criteria for liver cancer participants:\n\n* Individuals newly diagnosed with or suspected of having liver cancer (including hepatocellular carcinoma \\[HCC\\], intrahepatic cholangiocarcinoma \\[ICC\\], and combined hepatocellular-cholangiocarcinoma \\[cHCC-CCA\\]).\n* Individuals without any anti-cancer therapy prior to blood sample collection.\n\nInclusion Criteria for participants with benign liver diseases:\n\n* Individuals newly diagnosed as benign liver diseases before blood sample collection\n* Individuals without curative treatment for the disease before blood sample collection\n\nInclusion Criteria for participants with interfering cancers:\n\n* Individuals diagnosed with or suspected of having interfering cancer\n* Individuals without any anti-cancer therapy prior to blood sample collection\n\nInclusion Criteria for healthy participants:\n\n* No cancer-related or other clinical symptoms 30 days prior to blood sample collection\n* No prior history of benign liver diseases\n\nExclusion Criteria:\n\nExclusion Criteria for All the Participants:\n\n* Individuals cannot provide blood samples at the study-specified blood collection sites\n* Pregnancy or lactating women\n* Recipients of organ transplant or prior non-autologous (allogeneic) bone marrow transplant or stem cell transplant\n* Recipients of blood transfusion within 7 days prior to blood sample collection\n* Recipients of anti-infective treatment within 14 days prior to blood sample collection\n* Recipients of any anti-cancer therapy within 30 days prior to study blood draw, due to diseases other than cancer\n* Individuals with a history of malignant tumor\n\nExclusion Criteria for liver cancer participants:\n\n* Known prior or current diagnosis of other types of malignancies or multiple primary cancers\n* No confirmed diagnosis of liver cancer after blood sample collection\n\nExclusion Criteria for participants with benign liver diseases:\n\n* Individuals with a confirmed diagnosis of a malignant tumor or precancerous lesion\n* Individuals who cannot be diagnosed as having benign liver diseases after blood sample collection\n\nExclusion Criteria for participants with interfering cancers:\n\n* Known prior or current diagnosis of other types of malignancies or multiple primary cancers\n* No confirmed diagnosis of any type of interfering cancers after blood sample collection\n\nExclusion Criteria for healthy participants:\n\n* Prior or ongoing treatment of cancers within 3 years prior to blood sample collection\n* Clinically significant or uncontrolled comorbidities'}, 'identificationModule': {'nctId': 'NCT05996666', 'acronym': 'PRIMe-liver', 'briefTitle': 'Primary Liver Cancer Early Detection', 'organization': {'class': 'OTHER', 'fullName': 'The First Hospital of Jilin University'}, 'officialTitle': 'Early Detection of Primary Liver Cancer Based on cfDNA Methylation: A Multi-Center Case-Control Study (PRIMe-liver)', 'orgStudyIdInfo': {'id': 'RSCD2022015P'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'Liver cancer arm', 'description': 'Participants with new diagnosis of liver cancer, from whom blood samples will be collected.', 'interventionNames': ['Device: Liver-cancer early detection test']}, {'label': 'Benign diseases arm', 'description': 'Participants with benign diseases of cancer, from whom blood samples will be collected.', 'interventionNames': ['Device: Liver-cancer early detection test']}, {'label': 'Healthy arm', 'description': 'Participants without known presence of malignancies or benign diseases of liver, from whom blood samples will be collected.', 'interventionNames': ['Device: Liver-cancer early detection test']}, {'label': 'Interfering cancer arm', 'description': 'Participants with new diagnosis of interfering cancer types, from whom blood samples will be collected.', 'interventionNames': ['Device: Liver-cancer early detection test']}], 'interventions': [{'name': 'Liver-cancer early detection test', 'type': 'DEVICE', 'description': 'Blood collection and liver-cancer early detection test', 'armGroupLabels': ['Benign diseases arm', 'Healthy arm', 'Interfering cancer arm', 'Liver cancer arm']}]}, 'contactsLocationsModule': {'locations': [{'city': 'Changchun', 'state': 'Jilin', 'status': 'RECRUITING', 'country': 'China', 'contacts': [{'name': 'Bo Liu', 'role': 'CONTACT'}], 'facility': 'Jilin university first hospital', 'geoPoint': {'lat': 43.88, 'lon': 125.32278}}, {'city': 'Shanghai', 'state': 'Shanghai Municipality', 'status': 'RECRUITING', 'country': 'China', 'contacts': [{'name': 'Lanqing Yao', 'role': 'CONTACT'}], 'facility': 'Eastern Hepatobiliary Surgery Hospital', 'geoPoint': {'lat': 31.22222, 'lon': 121.45806}}], 'centralContacts': [{'name': 'Bo Liu', 'role': 'CONTACT', 'email': 'liuboliubo1109@163.com', 'phone': '18840110641'}, {'name': 'Shangli Cai', 'role': 'CONTACT', 'email': 'shangli.cai@brbiotech.com', 'phone': '86 021 61631938'}], 'overallOfficials': [{'name': 'Tian Yang', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Eastern Hepatobiliary Surgery Hospital'}, {'name': 'Nanya Wang', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'The First Hospital of Jilin University'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'The First Hospital of Jilin University', 'class': 'OTHER'}, 'collaborators': [{'name': 'Guangzhou Burning Rock Dx Co., Ltd.', 'class': 'INDUSTRY'}], 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Professor of Gastroenterology & Hepatology', 'investigatorFullName': 'Guoyue Lv', 'investigatorAffiliation': 'The First Hospital of Jilin University'}}}}